New trends in photobiology. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

Journal of Photochemistry and Photobiology, B: Biology

Volumn 14, Issue 4, 1992, Pages 275-292

  Kennedy, James C ^a,b   Pottier, Roy H ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b ROYAL MILITARY COLLEGE OF CANADA   (Canada)

Author keywords

5 aminolevulinic acid; cancer; photochemotherapy; Photodynamic therapy; porphyria.; protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

BASAL CELL CARCINOMA; CANCER; HUMAN; PHOTODYNAMIC THERAPY; REVIEW; TISSUE SPECIFICITY; TOPICAL DRUG ADMINISTRATION;

AMINOLEVULINIC ACID; ANIMAL; HEME; HUMAN; PHOTOCHEMOTHERAPY; PRODRUGS; PROTOPORPHYRINS; SUPPORT, NON-U.S. GOV'T;

EID: 0026775086     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/1011-1344(92)85108-7     Document Type: Review

References (96)

1. Experimental porphyric neuropathy: a preliminary report
2. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo
3. Phototoxic damage to sebaceous glands and hair follicles of mice following systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence
4. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience
5. Medical applications of selective tissue photosensitization induced by exogenous 5-aminolevulinic acid
6. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins
7. Destruction of erythroleukemic cells by photoactivation of endogenous porphyrins
8. Stimulation of Friend erythroleukemic cell cytodifferentiation by 5-aminolevulinic acid; porphyrins, cell size, segregation of sialoproteins, and nuclear translocation
9. 5-aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells
10. Studies on porphyrin-heme biosynthesis in organotypic cultures of chick dorsal root ganglion. I. Observations on neuronal and non-neuronal elements
11. Tetrapyrrole-dependent photodynamic herbicides
12. Photodynamic herbicides. 9. Structure activity study of substituted 1,10-phenanthrolines as potent photodynamic herbicide modulators
13. Porphyric insecticides. 1. Concept and phenomenology
14. Porphyric insecticides. 2. 1,10-phenanthroline, a potent porphyric insecticide modulator
15. Electron transport and oxidative phosphorylation
16. The porphyrias
17. Specific pattern of gene expression during induction of mouse erythroleukemia cells
18. Effects of succinylacetone on dimethylsulfoxide-mediated induction of heme pathway enzymes in mouse Friend virus-transformed erythroleukemia cells
19. Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus-infected cells
20. The relationship between heme synthesis and iron uptake in erythroid cells
21. Iron metabolism and the regulation of heme and ferritin synthesis in differentiating murine erythroleukemia cells
22. Inhibition of cellular iron uptake by haem in mouse erythroleukemia cells
23. Control of heme synthesis during Friend cell differentiation: role of iron and transferrin
24. The role of hemin in the regulation of heme synthesis by fetal mouse erythroblasts in culture
25. Urinary and fecal excretion of porphyrins and their precursors in leukemic patients
26. Studies on porphyrin biosynthesis in erythrocytes after incubation with delta-aminolevulinic acid in patients with acute leukemia
27. Heme control on the synthesis of delta-aminolevulinic acid synthetase in cultured chick embryo liver cells
28. Regulation of heme synthesis in the regenerating rat liver
29. Heme synthesis in normal mouse liver and mouse liver tumors
30. Delta-aminolaevulinate synthase in human HEPG2 hepatoma cells. Repression by haemin and induction by chemicals
31. Conversion of 5-aminolaevulinate into heme by liver homogenates. Comparison of rat and chick embryo
32. Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid
33. Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates
34. Quantitation of hydrogen peroxide formed during UV-visible irradiation of protoporphyrin, coproporphyrin and uroporphyrin
35. Biodistribution and selective in vivo tumor localization of endogenous porphyrins induced and stimulated by 5-aminolevulinic acid: a newly developed technique
36. Uroporphyria caused by acetone and 5-aminolevulinic acid in iron-loaded mice
37. Uroporphyrin accumulation in cultured chick embryo hepatocytes: comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,4,3′,4′-tetrachlorobiphenyl
38. Mechanisms of photosensitivity in porphyric patients with special emphasis on erythropoietic protoporphyria
39. Clearance times of porphyrin derivatives from mice as measured by in vivo fluorescence spectroscopy
40. Effect of extracellular pH upon the uptake of porphyrins by malignant cells
41. Synergistic induction of delta-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine
42. Heme precursor 5-aminolevulinic acid alters brain tryptophan and serotonin levels without changing pineal serotonin and melatonin concentrations
43. Pharmacological effects of haem biosynthetic intermediates in isolated intestinal preparations
44. An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities
45. Delta-aminolaevulinic acid and amino acid neurotransmitters
46. Effects of delta-aminolevulinic acid administration of social behaviour in the laboratory mouse
47. Inhibition of the evoked release of acetylcholine by the porphyrin precursor delta-aminolevalinic acid
48. Effect of delta-aminolevulinic acid on frog nerve-muscle junction
49. Delta-aminolevulinic acid: Influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria
50. Delta-aminolevulinic acid. Effect of a porphyrin precursor on an isolated neuronal preparation
51. The neurological manifestations of porphyria: a review
52. Porphyrin precursors and their effects in vitro on some aspects of nerve function
53. Neurochemistry of acute porphyria. Experimental studies on delta-aminolaevulinic acid and porphobilinogen
54. Some pharmacological and behavioural effects of delta-aminolaevulinic acid
55. The interaction of porphyrin precursors with GABA receptor in the isolated frog spinal cord
56. Neurochemical aspects of porphyria. Studies on the possible neurotoxicity of delta-aminolaevulinic acid
57. The effect of porphyrin precursors on monosynaptic reflex activity in the isolated hemisected frog spinal cord
58. The effect of delta-aminolaevulinic acid on the spontaneous activity of mice
59. Delta-aminolaevulinic acid in acute porphyria
60. The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid
61. Inhibition of sodium and water transport by delta-aminolaevulinic acid (ALA)
62. Presynaptic neuromuscular inhibition of porphobilinogen and porphobilin
63. Electroencephalographic and behavioral effects of experimental porphyria in the rat
64. Presynaptic neuromuscular inhibition by delta-aminolevulinic acid, a porphyrin precursor
65. Seizures in experimental porphyria
66. Studies on experimental porphyria in Les maladies du métabolisme des porphyrines
67. Delta-aminolaevulinic acid and porphyria
68. Porphobilinogen and delta-aminolevulinic acid in acute porphyria
69. Pharmacology of the porphyrins and porphobilinogen
70. Fate of porphobilinogen in the rat Relation to acute porphyria in man
71. The metabolism of the porphyrin precursor, delta-aminolaevulinic acid, in normal man and in the rat
72. Some aspects of porphyrin neurotoxicity in vitro
73. A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice
74. 15N
75. 14C
76. Photodynamic therapy in patient with xeroderma pigmentosum
77. Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas
78. Antipsoriasis and phototoxic effect of hematoporphyrin derivative following topical administration and irradiation with visible light
79. Photodynamic therapy of psoriasis palmaris et plantaris using a topically applied hematoporphyrin derivative and visible light
80. Topical administration of hematoporphyrin derivative and red light irradiation. A therapeutic approach in psoriasis
81. Topical administration of tetrasodium-meso-tetraphenylporphinesulfonate (TPPS): correlation between drug penetration and depth of necrosis in skin of nude mice following red light irradiation
82. Topical administration of tetrasodium-meso-tetraphenyl-porphinesulfonate (TPPS) and red light irradiation for the treatment of superficial neoplastic lesions
83. Preliminary clinical studies with PDT by topical TPPS administration in neoplastic skin lesions
84. Topical hematoporphyrin plus UVA for the treatment of alopecia areata
85. Results of PDT by TPPS topical administration and red light exposure in neoplastic skin lesions
86. PDT with topical injection of HpD in malignant tumors
87. Cutaneous photosensitization by topical hematoporphyrin derivative formulations: potential clinical applications
88. 131I-albumin in mice bearing Lewis lung carcinoma
89. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse
90. Porphyrins as tumor localization agents and their possible use in photochemotherapy of cancer
91. The possible role of ionic species in selective biodistribution of photochemotherapeutic agents towards neoplastic tissue
92. Effect of extracellular pH upon the uptake of porphyrins by malignant cells
93. Hematoporphyrin derivative photoradiation therapy, in theory and in practice